Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Pulmonology

Biology, Mimics & The Diagnostic Process

At a Glance

Idiopathic chronic eosinophilic pneumonia is diagnosed by combining symptom duration, eosinophil levels in blood or lung fluid, and CT findings while excluding infections, medication reactions, parasites, and related diseases. A lung biopsy is often unnecessary when the pattern is typical.

Diagnosing Idiopathic Chronic Eosinophilic Pneumonia (ICEP) is often a process of elimination. Because there is no single test that definitively “proves” you have ICEP, doctors must carefully evaluate your clinical picture and rule out other conditions that look similar before arriving at this diagnosis [1][2].

The Biology of ICEP: An Immune System Misfire

At its core, ICEP is an inflammatory disease thought to be driven by a specific branch of your immune system called the Th2 pathway [3].

  • The Driver (IL-5): Research suggests that people with ICEP produce elevated levels of a signaling protein called Interleukin-5 (IL-5). This protein acts like a “growth factor” for eosinophils, prompting the bone marrow to produce them in large numbers and helping them survive longer [4][5].
  • The Accumulation: These eosinophils are recruited into the lungs by chemical messengers. Once they arrive, they release inflammatory proteins intended to fight threats like parasites, but in ICEP, this response causes significant inflammation in your lung tissue [6][7].

A Diagnosis of Exclusion: Ruling Out the Mimics

Before your doctor can call your condition “idiopathic” (meaning no secondary cause has been identified), they must ensure your lung inflammation isn’t being triggered by something else. This is why ICEP is known as a diagnosis of exclusion [1]. Common “mimics” that must be ruled out include:

  • Drug or Toxin Reactions: Certain medications (like some antidepressants or antibiotics) and inhaled toxins can cause eosinophilic lung disease. Always provide your doctor with a complete list of your medications and supplements [8][9].
  • Infections and Parasites: Parasites (like roundworms or Strongyloides) and certain fungal infections can trigger a high eosinophil count. It is highly critical to report your travel history. If you have a hidden parasitic infection like Strongyloides, starting high-dose steroids can cause a life-threatening hyperinfection. Your doctor can test and treat for this before you start steroids [10][11].
  • ABPA (Allergic Bronchopulmonary Aspergillosis): This is an allergic reaction to a common mold (Aspergillus). It often affects people with asthma and is distinguished by specific Aspergillus-specific testing, very high total IgE (allergy antibody) levels, and characteristic imaging, though it can look like ICEP in some stages [12][13].
  • EGPA (Eosinophilic Granulomatosis with Polyangiitis): A rare systemic condition where eosinophils cause vasculitis (inflammation of the blood vessels). While EGPA usually involves other organs like the heart, skin, or nerves, it can initially present with only lung and asthma symptoms, making it hard to distinguish from ICEP at first. A lack of rashes or nerve pain does not rule it out [10][14].
  • AEP (Acute Eosinophilic Pneumonia): This is a distinct, much faster-moving condition, often developing in just a few days and causing rapid respiratory failure. It is frequently linked to a recent change in smoking or vaping habits [15][16].

Supportive Diagnostic Findings

To support a diagnosis of ICEP, your care team typically looks for clinical markers. These are not absolute “pass/fail” rules, but common reference points:

  1. High Eosinophil Counts:
    • In the Blood: A count of 1,000 eosinophils/mm³ or higher is classically seen, though counts can be lower if you’ve recently taken steroids or are early in the illness [1][17].
    • In the Lungs: Doctors may perform a Bronchoalveolar Lavage (BAL), where a small amount of fluid is used to “wash” a portion of the lung and then collected for testing. Finding that eosinophils make up 40% or more of the cells found in this fluid is highly supportive of ICEP, though a BAL is not required in every case [1][18].
  2. Classic Imaging: On a CT scan, ICEP often presents with patchy white areas around the outer edges (periphery) and the upper parts of the lungs (often called the “photographic negative of pulmonary edema”) [1][19].
  3. Symptom Duration: Symptoms have typically been present for two to four weeks or more, which helps distinguish it from acute (fast-moving) forms [1][15].

In most cases, if your clinical history, blood work, and scans match this pattern and mimics are ruled out, a lung biopsy (taking a physical piece of lung tissue) is not necessary [1][10]. A biopsy is usually reserved for atypical cases where the diagnosis remains unclear [20][21].

Common questions in this guide

How is idiopathic chronic eosinophilic pneumonia diagnosed?
There is no single test that proves idiopathic chronic eosinophilic pneumonia. Doctors combine the symptom pattern, blood or lung-fluid eosinophil levels, and CT findings while ruling out infections, medication reactions, parasites, and other similar conditions. A lung biopsy is often unnecessary when the overall pattern is typical.
What blood eosinophil level supports an ICEP diagnosis?
A blood eosinophil count of about 1,000 cells per cubic millimeter or higher is commonly seen in ICEP. A lower count does not exclude the condition if the illness is early or you recently took corticosteroids. The count supports the diagnosis but does not confirm it by itself.
What can a bronchoalveolar lavage show in ICEP?
During bronchoalveolar lavage, doctors wash a small area of the lung with fluid and test the fluid that is collected. Eosinophils making up about 40% or more of the cells in that fluid strongly support ICEP, although this procedure is not needed in every case.
What does an ICEP CT scan usually look like?
A CT scan may show patchy areas of inflammation along the outer edges and upper parts of the lungs. This pattern is sometimes called the photographic negative of pulmonary edema. Imaging can support ICEP, but it must be interpreted with symptoms and other test results.
Why are travel history and medications important before starting steroids for ICEP?
Some medicines, inhaled toxins, parasites, and infections can cause lung inflammation that resembles ICEP. A hidden Strongyloides infection can become life-threatening after high-dose steroids, so your doctor may test for and treat it before steroid therapy when your exposure history suggests a risk.
How is ICEP different from ABPA, EGPA, and acute eosinophilic pneumonia?
ABPA is an allergic reaction to Aspergillus and is often linked to asthma, while EGPA can affect organs such as the heart, skin, or nerves. Acute eosinophilic pneumonia usually develops over days and may follow a change in smoking or vaping, whereas ICEP generally develops over weeks. Doctors use medical history, blood tests, imaging, and other evaluations to tell them apart.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my absolute blood eosinophil count, and did it indicate high levels?
  2. 2.During the BAL procedure, what percentage of eosinophils were found in my lung fluid?
  3. 3.Does my CT scan show patterns that are supportive of ICEP?
  4. 4.How have we ruled out other conditions like ABPA, EGPA, or parasitic infections?
  5. 5.Given my travel history, should I be tested for Strongyloides or other parasites before starting steroids?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids.

    Chan C, DeLapp D, Nystrom P

    Respiratory medicine case reports 2017; (22()):11-14 doi:10.1016/j.rmcr.2017.05.014.

    PMID: 28626631
  2. 2

    Eosinophilic Lung Diseases.

    Cottin V

    Clinics in chest medicine 2025; (46(4)):667-684 doi:10.1016/j.ccm.2025.07.007.

    PMID: 41110928
  3. 3

    Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.

    Katoh S, Ikeda M, Matsumoto N, et al.

    Lung 2017; (195(6)):707-712 doi:10.1007/s00408-017-0048-8.

    PMID: 28875265
  4. 4

    Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions.

    Harish A, Schwartz SA

    Clinical reviews in allergy & immunology 2020; (59(2)):231-247 doi:10.1007/s12016-019-08775-4.

    PMID: 31919743
  5. 5

    Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders.

    Olivieri B, Tinazzi E, Caminati M, Lunardi C

    Immunology and allergy clinics of North America 2020; (40(4)):649-665 doi:10.1016/j.iac.2020.07.001.

    PMID: 33012326
  6. 6

    Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia.

    Nakagome K, Nagata M

    Biomolecules 2020; (10(4)) doi:10.3390/biom10040638.

    PMID: 32326200
  7. 7

    Eosinophil extracellular traps in a patient with chronic eosinophilic pneumonia.

    Takeda M, Sakamoto S, Ueki S, et al.

    Asia Pacific allergy 2021; (11(3)):e24 doi:10.5415/apallergy.2021.11.e24.

    PMID: 34386400
  8. 8

    Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases.

    Barry J, Gadre A, Akuthota P

    Current opinion in immunology 2020; (66()):129-135 doi:10.1016/j.coi.2020.10.005.

    PMID: 33166785
  9. 9

    [Sertraline-induced chronic eosinophilic pneumonia].

    Brancaleone P, Descamps O, Piquet M, et al.

    Revue des maladies respiratoires 2021; (38(2)):210-214 doi:10.1016/j.rmr.2020.11.012.

    PMID: 33581985
  10. 10

    Eosinophilic Lung Diseases.

    Cottin V

    Immunology and allergy clinics of North America 2023; (43(2)):289-322 doi:10.1016/j.iac.2023.01.002.

    PMID: 37055090
  11. 11

    Pneumothorax with Eosinophilia is an Important Diagnostic Clue for Distinguishing Paragonimiasis from Chronic Eosinophilic Pneumonia: A Case Report.

    Sakakura S, Yamaguchi F, Abe T, et al.

    Infection and drug resistance 2023; (16()):2429-2432 doi:10.2147/IDR.S402392.

    PMID: 37138842
  12. 12

    Allergic bronchopulmonary aspergillosis.

    Patel G, Greenberger PA

    Allergy and asthma proceedings 2019; (40(6)):421-424 doi:10.2500/aap.2019.40.4262.

    PMID: 31690385
  13. 13

    CT Findings of Asthma and Asthma-Mimicking Conditions.

    Al-Sergani AH, Zaini RH, Alsergani AH, et al.

    Cureus 2026; (18(5)):e108457 doi:10.7759/cureus.108457.

    PMID: 42261548
  14. 14

    Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.

    Zimmermann N, Wikenheiser-Brokamp KA

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2018; (121(2)):179-185 doi:10.1016/j.anai.2018.05.014.

    PMID: 29803709
  15. 15

    Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment.

    Giovannini-Chami L, Blanc S, Hadchouel A, et al.

    Pediatric pulmonology 2016; (51(2)):203-16 doi:10.1002/ppul.23368.

    PMID: 26716396
  16. 16

    Acute Eosinophilic Pneumonia. Causes, Diagnosis, and Management.

    De Giacomi F, Vassallo R, Yi ES, Ryu JH

    American journal of respiratory and critical care medicine 2018; (197(6)):728-736 doi:10.1164/rccm.201710-1967CI.

    PMID: 29206477
  17. 17

    Evaluating the relationship between high-resolution computed tomography findings and their extent in eosinophilic lung diseases with peripheral blood eosinophil level.

    Mehrian P, Kiani A, Bandegani N, et al.

    Polish journal of radiology 2021; (86()):e542-e547 doi:10.5114/pjr.2021.110643.

    PMID: 34820030
  18. 18

    Eosinophilic Lung Diseases.

    Cottin V

    Clinics in chest medicine 2016; (37(3)):535-56.

    PMID: 27514599
  19. 19

    Bronchial involvement in chronic eosinophilic pneumonia: a case report.

    Kim NH, Lee KH, Kim JH, et al.

    Journal of thoracic disease 2015; (7(4)):E97-E101 doi:10.3978/j.issn.2072-1439.2014.12.16.

    PMID: 25973261
  20. 20

    Clinical characteristics of patients with chronic eosinophilic pneumonia in a Chinese tertiary-care hospital: A 6-year retrospective study.

    Xu Y, Wang Z, Li W, et al.

    The clinical respiratory journal 2022; (16(1)):35-42 doi:10.1111/crj.13448.

    PMID: 34610651
  21. 21

    Case Report: Chronic eosinophilic pneumonia with acute-like presentation and diagnostic challenges.

    Zamfir AS, Mihailovici AS, Mihai F, et al.

    Frontiers in medicine 2026; (13()):1841565 doi:10.3389/fmed.2026.1841565.

    PMID: 42318416

This page explains how doctors evaluate ICEP and rule out similar lung diseases for informational purposes only and does not constitute medical advice. Discuss your results, travel history, and steroid safety with your healthcare team.

Get notified when new evidence is published on Idiopathic chronic eosinophilic pneumonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.